South Wales, Oct. 24 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "OSTIA" on Oct. 2. The details about the trademark application no. UK00004272703 published in the journal no. 2025/043 (Oct. 24).
With CMS Cameron McKenna Nabarro Olswang LLP as representative, Ostia Sciences Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Biological preparations, namely bacteria for the production of biochemicals, probiotic bacterial cultures for scientific research, biological virus specimens for use in scientific research; probiotic bacterial compositions for use as ingredients for food and beverages; probiotic bacteria for the food industry; bacteria strains, namely probiotic bacteria and bacterial cultures; probiotic bacterial cultures for the food industry, probiotic bacterial cultures for scientific research; microbes for use in the manufacture of probiotic supplements; bacterial preparations other than for medical for use in the manufacture of food; bacterial cultures for addition to food products.
Class 5 : Probiotic supplements for medical purposes to help maintain a natural balance of flora in the digestive system; probiotic preparations for throat and dental health; probiotic preparations for throat and respiratory tract health; probiotic preparations for medical purposes to help regulate the immune system; probiotic preparations for oral care and oral hygiene; probiotic preparations for the treatment of bad breath and halitosis; probiotic preparations for the treatment of gingivitis and periodontal diseases; probiotic preparations for the treatment of peri-implantitis; probiotic preparations for the treatment of dental caries and cavities; probiotic preparations for the treatment of nasal infections; probiotic preparations for ear health; probiotic preparations to aid in the prevention of recurring ear infections; medicated mouth rinses, medicated mouth sprays, and medicated mouthwashes, oral anaesthetics, oral analgesics; probiotic preparations for the prevention of pneumonia; pharmaceutical preparations, namely, preparations containing naturally occurring bacteria beneficial to use in the treatment of infections of the mouth and airways; products for oral care and oral hygiene, namely pharmaceutical preparations for the treatment of dental and oral diseases; breath fresheners for the treatment of halitosis; medicated confectionery, namely lozenges, cough drops and chewing gum for the treatment of dental and oral diseases and for treating halitosis; beverages containing probiotics for use as nutritional supplements; nutritional supplements containing probiotics for general health and well-being; nutritional supplements containing probiotics for maintenance of throat and mouth health; dietetic substances consisting of probiotics for medical purposes.
Class 42 : Conducting evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technologies for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals; consulting services for others in the field of design, planning, and implementation of clinical trials; Research and development services in the field of biotechnology.
Class 44 : Consulting services in the field of microbiome health and in the field of pharmaceutical and natural health products.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004272703
Disclaimer: Curated by HT Syndication.
